跳至主要内容
临床试验/JPRN-UMIN000010624
JPRN-UMIN000010624已完成未知

Vildagliptin and biguanide on postprandial blood glucose and vascular endothelial function in type 2 diabetic patients with coronary artery disease - VIBRATE-J study

Department of Cardiology, Juntendo University School of Medicine0 个研究点目标入组 20 人开始时间: 2013年5月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who has a history of adverse events with vildagliptin or biganide 2) Patients treated with antidiabetes agents 3) Ongoing treatment with insulin 4) Patients with diabetic ketoacidosis or diabetic coma or type 1 diabetes 5) Patients with severe liver dysfunction 6) Patients with moderate or severe renal disorders (creatinine level >= 1.5 mg/dL [men] or >= 1.3 mg/dL [women]) 7) Pregnant or nursing women 8) Patients with severe illness 9) Patients who judged as ineligible by clinical investigators

研究者

发起方
Department of Cardiology, Juntendo University School of Medicine

相似试验